NDC Package 50474-700-62 Cimzia Kit - NDC List
Cimzia. Non-Proprietary Name: Certolizumab Pegol. Usage Information: This medication is used to reduce pain and swelling due to certain inflammatory conditions (such as rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, plaque psoriasis).
NDC Package 50474-710-81 Cimzia Injection, Solution Subcutaneous - NDC …
Cimzia. Non-Proprietary Name: Certolizumab Pegol. Substance Name: Certolizumab Pegol. Usage Information: This medication is used to reduce pain and swelling due to certain inflammatory conditions (such as rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, plaque psoriasis).
NDC 50474-700 Cimzia Kit - NDC List
The NDC code 50474-700 is assigned by the FDA to the product Cimzia which is a human prescription drug product labeled by Ucb, Inc.. The generic name of Cimzia is certolizumab pegol. The product's dosage form is kit.
Cimzia® Certolizumab Pegol 200 mg / mL Injection - McKesson
Includes (2) alcohol swabs and (2) single use prefilled glass syringes with a fixed 25-1/2 gauge thin-wall needle, each containing 200 mg (1mL) of CIMZIA
DailyMed - CIMZIA- certolizumab pegol kit CIMZIA
2023年1月3日 — Prefilled Syringe NDC 50474-710-79 CIMZIA (certolizumab pegol) injection is supplied as a sterile, clear to opalescent, colorless to pale yellow solution in a single-dose prefilled syringe for subcutaneous use.
CIMZIA is a tumor necrosis factor (TNF) blocker indicated for: Reducing signs and symptoms of Crohn’s disease and maintaining clinical response in adult patients with moderately to severely...
CIMZIA is a tumor necrosis factor (TNF) blocker indicated for: Reducing signs and symptoms of Crohn’s disease and maintaining clinical response in adult patients with moderately to severely...
Cimzia - National Drug Codes - NDC List
List of products in the National Drug Code with proprietary name cimzia. This medication is used to reduce pain and swelling due to certain inflammatory conditions (such as rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, plaque psoriasis).
CIMZIA is a tumor necrosis factor (TNF) blocker indicated for: Reducing signs and symptoms of Crohn’s disease and maintaining clinical response in adult patients with moderately to severely...
Cimzia is medically necessary for the treatment of ankylosing spondylitis (AS) and non-radiographic axial spondyloarthritis (nr-axSpA) when all of the following criteria are met: For
- 某些结果已被删除